nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0869	0.11	CbGbCtD
Cefadroxil—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0774	0.0981	CbGbCtD
Cefadroxil—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0748	0.0948	CbGbCtD
Cefadroxil—SLC15A2—Ramipril—type 2 diabetes mellitus	0.069	0.0874	CbGbCtD
Cefadroxil—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0667	0.0845	CbGbCtD
Cefadroxil—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0658	0.0834	CbGbCtD
Cefadroxil—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0594	0.0753	CbGbCtD
Cefadroxil—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0567	0.0718	CbGbCtD
Cefadroxil—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0445	0.0563	CbGbCtD
Cefadroxil—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0412	0.0522	CbGbCtD
Cefadroxil—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0383	0.0485	CbGbCtD
Cefadroxil—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0367	0.0466	CbGbCtD
Cefadroxil—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0312	0.0396	CbGbCtD
Cefadroxil—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0211	0.0267	CbGbCtD
Cefadroxil—SLC22A6—Losartan—type 2 diabetes mellitus	0.0193	0.0245	CbGbCtD
Cefadroxil—Cefazolin—PON1—type 2 diabetes mellitus	0.00104	0.439	CrCbGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000531	0.0314	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000493	0.0292	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000318	0.0188	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000288	0.017	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000277	0.00146	CcSEcCtD
Cefadroxil—Rash—Repaglinide—type 2 diabetes mellitus	0.000277	0.00146	CcSEcCtD
Cefadroxil—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000277	0.00146	CcSEcCtD
Cefadroxil—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000276	0.00146	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00146	CcSEcCtD
Cefadroxil—Headache—Repaglinide—type 2 diabetes mellitus	0.000275	0.00145	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—type 2 diabetes mellitus	0.000275	0.116	CrCbGaD
Cefadroxil—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000274	0.00145	CcSEcCtD
Cefadroxil—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000274	0.00144	CcSEcCtD
Cefadroxil—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000273	0.00144	CcSEcCtD
Cefadroxil—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00144	CcSEcCtD
Cefadroxil—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000272	0.00143	CcSEcCtD
Cefadroxil—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000269	0.00142	CcSEcCtD
Cefadroxil—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00142	CcSEcCtD
Cefadroxil—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000268	0.00142	CcSEcCtD
Cefadroxil—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000268	0.00142	CcSEcCtD
Cefadroxil—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000268	0.00141	CcSEcCtD
Cefadroxil—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000268	0.00141	CcSEcCtD
Cefadroxil—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000267	0.00141	CcSEcCtD
Cefadroxil—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000267	0.00141	CcSEcCtD
Cefadroxil—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000267	0.00141	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00139	CcSEcCtD
Cefadroxil—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000263	0.00139	CcSEcCtD
Cefadroxil—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000262	0.00138	CcSEcCtD
Cefadroxil—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000262	0.00138	CcSEcCtD
Cefadroxil—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000261	0.00138	CcSEcCtD
Cefadroxil—Nausea—Repaglinide—type 2 diabetes mellitus	0.000261	0.00138	CcSEcCtD
Cefadroxil—Asthenia—Glipizide—type 2 diabetes mellitus	0.000261	0.00138	CcSEcCtD
Cefadroxil—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00026	0.00137	CcSEcCtD
Cefadroxil—Angioedema—Valsartan—type 2 diabetes mellitus	0.000258	0.00136	CcSEcCtD
Cefadroxil—Pruritus—Glipizide—type 2 diabetes mellitus	0.000257	0.00136	CcSEcCtD
Cefadroxil—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000256	0.00135	CcSEcCtD
Cefadroxil—Angioedema—Orlistat—type 2 diabetes mellitus	0.000255	0.00135	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000255	0.00134	CcSEcCtD
Cefadroxil—Vertigo—Valsartan—type 2 diabetes mellitus	0.000254	0.00134	CcSEcCtD
Cefadroxil—Vertigo—Orlistat—type 2 diabetes mellitus	0.000251	0.00132	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00025	0.0148	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00132	CcSEcCtD
Cefadroxil—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00025	0.00132	CcSEcCtD
Cefadroxil—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00025	0.00132	CcSEcCtD
Cefadroxil—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000249	0.00131	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000249	0.00131	CcSEcCtD
Cefadroxil—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000249	0.00131	CcSEcCtD
Cefadroxil—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000248	0.00131	CcSEcCtD
Cefadroxil—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000247	0.00131	CcSEcCtD
Cefadroxil—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000247	0.0013	CcSEcCtD
Cefadroxil—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000246	0.0013	CcSEcCtD
Cefadroxil—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000246	0.0013	CcSEcCtD
Cefadroxil—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000243	0.00128	CcSEcCtD
Cefadroxil—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000243	0.00128	CcSEcCtD
Cefadroxil—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000242	0.00128	CcSEcCtD
Cefadroxil—Convulsion—Orlistat—type 2 diabetes mellitus	0.000242	0.00128	CcSEcCtD
Cefadroxil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00128	CcSEcCtD
Cefadroxil—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00128	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000241	0.00127	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000241	0.0143	CbGpPWpGaD
Cefadroxil—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000241	0.00127	CcSEcCtD
Cefadroxil—Dizziness—Glipizide—type 2 diabetes mellitus	0.00024	0.00127	CcSEcCtD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00024	0.0142	CbGpPWpGaD
Cefadroxil—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00024	0.00127	CcSEcCtD
Cefadroxil—Cefonicid—ALB—type 2 diabetes mellitus	0.000239	0.101	CrCbGaD
Cefadroxil—Tension—Irbesartan—type 2 diabetes mellitus	0.000238	0.00126	CcSEcCtD
Cefadroxil—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000238	0.00126	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000237	0.014	CbGpPWpGaD
Cefadroxil—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000236	0.00125	CcSEcCtD
Cefadroxil—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000234	0.00124	CcSEcCtD
Cefadroxil—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000234	0.00123	CcSEcCtD
Cefadroxil—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000232	0.00122	CcSEcCtD
Cefadroxil—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00122	CcSEcCtD
Cefadroxil—Vomiting—Glipizide—type 2 diabetes mellitus	0.000231	0.00122	CcSEcCtD
Cefadroxil—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000231	0.00122	CcSEcCtD
Cefadroxil—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00023	0.00121	CcSEcCtD
Cefadroxil—Rash—Glipizide—type 2 diabetes mellitus	0.000229	0.00121	CcSEcCtD
Cefadroxil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000229	0.00121	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000229	0.00121	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000229	0.00121	CcSEcCtD
Cefadroxil—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000228	0.0012	CcSEcCtD
Cefadroxil—Headache—Glipizide—type 2 diabetes mellitus	0.000228	0.0012	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000226	0.0134	CbGpPWpGaD
Cefadroxil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000226	0.00119	CcSEcCtD
Cefadroxil—Tension—Losartan—type 2 diabetes mellitus	0.000224	0.00118	CcSEcCtD
Cefadroxil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000224	0.00118	CcSEcCtD
Cefadroxil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000223	0.00118	CcSEcCtD
Cefadroxil—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000223	0.00118	CcSEcCtD
Cefadroxil—Urticaria—Glyburide—type 2 diabetes mellitus	0.000222	0.00117	CcSEcCtD
Cefadroxil—Nervousness—Losartan—type 2 diabetes mellitus	0.000222	0.00117	CcSEcCtD
Cefadroxil—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000222	0.00117	CcSEcCtD
Cefadroxil—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000221	0.00117	CcSEcCtD
Cefadroxil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000221	0.00117	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00022	0.013	CbGpPWpGaD
Cefadroxil—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00022	0.00116	CcSEcCtD
Cefadroxil—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000219	0.00116	CcSEcCtD
Cefadroxil—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000218	0.00115	CcSEcCtD
Cefadroxil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000218	0.00115	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000218	0.0129	CbGpPWpGaD
Cefadroxil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000217	0.00114	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000217	0.0128	CbGpPWpGaD
Cefadroxil—Nausea—Glipizide—type 2 diabetes mellitus	0.000216	0.00114	CcSEcCtD
Cefadroxil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000216	0.00114	CcSEcCtD
Cefadroxil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000215	0.00113	CcSEcCtD
Cefadroxil—Rash—Glimepiride—type 2 diabetes mellitus	0.000214	0.00113	CcSEcCtD
Cefadroxil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000214	0.00113	CcSEcCtD
Cefadroxil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Cefadroxil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Cefadroxil—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Cefadroxil—Headache—Glimepiride—type 2 diabetes mellitus	0.000212	0.00112	CcSEcCtD
Cefadroxil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00112	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00021	0.00111	CcSEcCtD
Cefadroxil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Cefadroxil—Angioedema—Losartan—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000208	0.0011	CcSEcCtD
Cefadroxil—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000207	0.00109	CcSEcCtD
Cefadroxil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000206	0.00109	CcSEcCtD
Cefadroxil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000206	0.00109	CcSEcCtD
Cefadroxil—Vertigo—Losartan—type 2 diabetes mellitus	0.000205	0.00108	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000205	0.00108	CcSEcCtD
Cefadroxil—Somnolence—Valsartan—type 2 diabetes mellitus	0.000205	0.00108	CcSEcCtD
Cefadroxil—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000203	0.00107	CcSEcCtD
Cefadroxil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00107	CcSEcCtD
Cefadroxil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000201	0.00106	CcSEcCtD
Cefadroxil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00106	CcSEcCtD
Cefadroxil—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000201	0.00106	CcSEcCtD
Cefadroxil—Asthenia—Glyburide—type 2 diabetes mellitus	0.000201	0.00106	CcSEcCtD
Cefadroxil—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Cefadroxil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000198	0.00105	CcSEcCtD
Cefadroxil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000198	0.00105	CcSEcCtD
Cefadroxil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000198	0.00105	CcSEcCtD
Cefadroxil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000198	0.00104	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000197	0.00104	CcSEcCtD
Cefadroxil—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000196	0.102	CbGeAlD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000196	0.0116	CbGpPWpGaD
Cefadroxil—Arthralgia—Losartan—type 2 diabetes mellitus	0.000195	0.00103	CcSEcCtD
Cefadroxil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00103	CcSEcCtD
Cefadroxil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Cefadroxil—Rash—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00102	CcSEcCtD
Cefadroxil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00102	CcSEcCtD
Cefadroxil—Tension—Ramipril—type 2 diabetes mellitus	0.000192	0.00102	CcSEcCtD
Cefadroxil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000191	0.00101	CcSEcCtD
Cefadroxil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000191	0.00101	CcSEcCtD
Cefadroxil—Nervousness—Ramipril—type 2 diabetes mellitus	0.00019	0.001	CcSEcCtD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000189	0.0112	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000189	0.000996	CcSEcCtD
Cefadroxil—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000188	0.000995	CcSEcCtD
Cefadroxil—Somnolence—Metformin—type 2 diabetes mellitus	0.000187	0.000986	CcSEcCtD
Cefadroxil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000187	0.000985	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000186	0.000984	CcSEcCtD
Cefadroxil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000185	0.000976	CcSEcCtD
Cefadroxil—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000185	0.000976	CcSEcCtD
Cefadroxil—Urticaria—Valsartan—type 2 diabetes mellitus	0.000183	0.000967	CcSEcCtD
Cefadroxil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000183	0.000964	CcSEcCtD
Cefadroxil—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000182	0.000962	CcSEcCtD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000182	0.0108	CbGpPWpGaD
Cefadroxil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000182	0.000959	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000181	0.000957	CcSEcCtD
Cefadroxil—Urticaria—Orlistat—type 2 diabetes mellitus	0.000181	0.000956	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000181	0.000953	CcSEcCtD
Cefadroxil—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00018	0.000951	CcSEcCtD
Cefadroxil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00018	0.000951	CcSEcCtD
Cefadroxil—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00018	0.000951	CcSEcCtD
Cefadroxil—Angioedema—Ramipril—type 2 diabetes mellitus	0.000179	0.000945	CcSEcCtD
Cefadroxil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000178	0.000938	CcSEcCtD
Cefadroxil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000178	0.000938	CcSEcCtD
Cefadroxil—Rash—Glyburide—type 2 diabetes mellitus	0.000176	0.000931	CcSEcCtD
Cefadroxil—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000176	0.00093	CcSEcCtD
Cefadroxil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000176	0.00093	CcSEcCtD
Cefadroxil—Vertigo—Ramipril—type 2 diabetes mellitus	0.000176	0.000929	CcSEcCtD
Cefadroxil—Headache—Glyburide—type 2 diabetes mellitus	0.000175	0.000925	CcSEcCtD
Cefadroxil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000921	CcSEcCtD
Cefadroxil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000172	0.000907	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000172	0.000907	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000171	0.000903	CcSEcCtD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000171	0.0101	CbGpPWpGaD
Cefadroxil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00017	0.000897	CcSEcCtD
Cefadroxil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00017	0.000897	CcSEcCtD
Cefadroxil—Convulsion—Ramipril—type 2 diabetes mellitus	0.00017	0.000896	CcSEcCtD
Cefadroxil—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000168	0.0872	CbGeAlD
Cefadroxil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000168	0.000886	CcSEcCtD
Cefadroxil—Urticaria—Metformin—type 2 diabetes mellitus	0.000167	0.000881	CcSEcCtD
Cefadroxil—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000167	0.000881	CcSEcCtD
Cefadroxil—Nausea—Glyburide—type 2 diabetes mellitus	0.000166	0.000877	CcSEcCtD
Cefadroxil—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000166	0.000876	CcSEcCtD
Cefadroxil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000166	0.000876	CcSEcCtD
Cefadroxil—Somnolence—Losartan—type 2 diabetes mellitus	0.000166	0.000875	CcSEcCtD
Cefadroxil—Asthenia—Valsartan—type 2 diabetes mellitus	0.000165	0.000874	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000165	0.00975	CbGpPWpGaD
Cefadroxil—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000164	0.000867	CcSEcCtD
Cefadroxil—Asthenia—Orlistat—type 2 diabetes mellitus	0.000164	0.000863	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000163	0.00967	CbGpPWpGaD
Cefadroxil—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000163	0.0848	CbGeAlD
Cefadroxil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000163	0.000861	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000162	0.000856	CcSEcCtD
Cefadroxil—Pruritus—Orlistat—type 2 diabetes mellitus	0.000161	0.000851	CcSEcCtD
Cefadroxil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00016	0.000844	CcSEcCtD
Cefadroxil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00016	0.000843	CcSEcCtD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000159	0.00939	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000158	0.00937	CbGpPWpGaD
Cefadroxil—Rash—Gliclazide—type 2 diabetes mellitus	0.000158	0.000836	CcSEcCtD
Cefadroxil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000158	0.000835	CcSEcCtD
Cefadroxil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000158	0.000833	CcSEcCtD
Cefadroxil—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000157	0.000831	CcSEcCtD
Cefadroxil—Headache—Gliclazide—type 2 diabetes mellitus	0.000157	0.00083	CcSEcCtD
Cefadroxil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.000827	CcSEcCtD
Cefadroxil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000157	0.000827	CcSEcCtD
Cefadroxil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000157	0.000827	CcSEcCtD
Cefadroxil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000156	0.000823	CcSEcCtD
Cefadroxil—Cefradine—CYP3A4—type 2 diabetes mellitus	0.000155	0.0654	CrCbGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000153	0.00905	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000153	0.000805	CcSEcCtD
Cefadroxil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000153	0.000805	CcSEcCtD
Cefadroxil—Dizziness—Orlistat—type 2 diabetes mellitus	0.000151	0.000796	CcSEcCtD
Cefadroxil—Asthenia—Metformin—type 2 diabetes mellitus	0.000151	0.000795	CcSEcCtD
Cefadroxil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000149	0.000787	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000149	0.00881	CbGpPWpGaD
Cefadroxil—Pruritus—Metformin—type 2 diabetes mellitus	0.000149	0.000784	CcSEcCtD
Cefadroxil—Urticaria—Losartan—type 2 diabetes mellitus	0.000148	0.000782	CcSEcCtD
Cefadroxil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000147	0.000778	CcSEcCtD
Cefadroxil—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000147	0.000778	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000147	0.0087	CbGpPWpGaD
Cefadroxil—Vomiting—Valsartan—type 2 diabetes mellitus	0.000147	0.000774	CcSEcCtD
Cefadroxil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000146	0.000771	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000146	0.000769	CcSEcCtD
Cefadroxil—Rash—Valsartan—type 2 diabetes mellitus	0.000145	0.000768	CcSEcCtD
Cefadroxil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000145	0.000767	CcSEcCtD
Cefadroxil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000145	0.000765	CcSEcCtD
Cefadroxil—Headache—Valsartan—type 2 diabetes mellitus	0.000144	0.000763	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000144	0.00855	CbGpPWpGaD
Cefadroxil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000144	0.000759	CcSEcCtD
Cefadroxil—Rash—Orlistat—type 2 diabetes mellitus	0.000144	0.000759	CcSEcCtD
Cefadroxil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000144	0.000758	CcSEcCtD
Cefadroxil—SLC15A1—kidney—type 2 diabetes mellitus	0.000144	0.0745	CbGeAlD
Cefadroxil—Headache—Orlistat—type 2 diabetes mellitus	0.000143	0.000754	CcSEcCtD
Cefadroxil—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000142	0.000751	CcSEcCtD
Cefadroxil—Somnolence—Ramipril—type 2 diabetes mellitus	0.000142	0.000751	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000142	0.0084	CbGpPWpGaD
Cefadroxil—Cefoperazone—ALB—type 2 diabetes mellitus	0.000141	0.0595	CrCbGaD
Cefadroxil—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000141	0.000743	CcSEcCtD
Cefadroxil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00014	0.00074	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00014	0.00826	CbGpPWpGaD
Cefadroxil—Dizziness—Metformin—type 2 diabetes mellitus	0.000139	0.000733	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.000729	CcSEcCtD
Cefadroxil—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000137	0.000725	CcSEcCtD
Cefadroxil—Nausea—Valsartan—type 2 diabetes mellitus	0.000137	0.000723	CcSEcCtD
Cefadroxil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000136	0.000716	CcSEcCtD
Cefadroxil—Nausea—Orlistat—type 2 diabetes mellitus	0.000135	0.000715	CcSEcCtD
Cefadroxil—Asthenia—Losartan—type 2 diabetes mellitus	0.000134	0.000706	CcSEcCtD
Cefadroxil—Vomiting—Metformin—type 2 diabetes mellitus	0.000134	0.000705	CcSEcCtD
Cefadroxil—Rash—Metformin—type 2 diabetes mellitus	0.000132	0.000699	CcSEcCtD
Cefadroxil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000132	0.000698	CcSEcCtD
Cefadroxil—Pruritus—Losartan—type 2 diabetes mellitus	0.000132	0.000697	CcSEcCtD
Cefadroxil—Headache—Metformin—type 2 diabetes mellitus	0.000132	0.000695	CcSEcCtD
Cefadroxil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000131	0.000692	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000131	0.00069	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000131	0.00773	CbGpPWpGaD
Cefadroxil—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000128	0.000674	CcSEcCtD
Cefadroxil—Urticaria—Ramipril—type 2 diabetes mellitus	0.000127	0.000671	CcSEcCtD
Cefadroxil—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000126	0.000667	CcSEcCtD
Cefadroxil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000126	0.000667	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000126	0.00747	CbGpPWpGaD
Cefadroxil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000126	0.000665	CcSEcCtD
Cefadroxil—Rash—Irbesartan—type 2 diabetes mellitus	0.000125	0.00066	CcSEcCtD
Cefadroxil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000125	0.000659	CcSEcCtD
Cefadroxil—Nausea—Metformin—type 2 diabetes mellitus	0.000125	0.000659	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000125	0.00738	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000124	0.00736	CbGpPWpGaD
Cefadroxil—Headache—Irbesartan—type 2 diabetes mellitus	0.000124	0.000655	CcSEcCtD
Cefadroxil—Dizziness—Losartan—type 2 diabetes mellitus	0.000123	0.000651	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000122	0.00724	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000121	0.00714	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.00012	0.0071	CbGpPWpGaD
Cefadroxil—Ampicillin—ALB—type 2 diabetes mellitus	0.00012	0.0506	CrCbGaD
Cefadroxil—Vomiting—Losartan—type 2 diabetes mellitus	0.000119	0.000626	CcSEcCtD
Cefadroxil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000118	0.000622	CcSEcCtD
Cefadroxil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000118	0.000621	CcSEcCtD
Cefadroxil—Rash—Losartan—type 2 diabetes mellitus	0.000118	0.000621	CcSEcCtD
Cefadroxil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000118	0.00062	CcSEcCtD
Cefadroxil—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000117	0.061	CbGeAlD
Cefadroxil—Headache—Losartan—type 2 diabetes mellitus	0.000117	0.000617	CcSEcCtD
Cefadroxil—Cefazolin—ALB—type 2 diabetes mellitus	0.000116	0.0489	CrCbGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000116	0.00685	CbGpPWpGaD
Cefadroxil—Asthenia—Ramipril—type 2 diabetes mellitus	0.000115	0.000606	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000114	0.00673	CbGpPWpGaD
Cefadroxil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000113	0.000597	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000112	0.00662	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000111	0.00659	CbGpPWpGaD
Cefadroxil—Nausea—Losartan—type 2 diabetes mellitus	0.000111	0.000585	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000111	0.00654	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00011	0.00651	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000109	0.00648	CbGpPWpGaD
Cefadroxil—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000109	0.000578	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000109	0.00646	CbGpPWpGaD
Cefadroxil—SLC15A2—retina—type 2 diabetes mellitus	0.000108	0.0563	CbGeAlD
Cefadroxil—Dizziness—Ramipril—type 2 diabetes mellitus	0.000106	0.000558	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000105	0.00623	CbGpPWpGaD
Cefadroxil—SLC22A8—kidney—type 2 diabetes mellitus	0.000103	0.0536	CbGeAlD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000103	0.00609	CbGpPWpGaD
Cefadroxil—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000102	0.053	CbGeAlD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000102	0.00604	CbGpPWpGaD
Cefadroxil—Vomiting—Ramipril—type 2 diabetes mellitus	0.000102	0.000537	CcSEcCtD
Cefadroxil—Rash—Ramipril—type 2 diabetes mellitus	0.000101	0.000532	CcSEcCtD
Cefadroxil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000101	0.000532	CcSEcCtD
Cefadroxil—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000101	0.0522	CbGeAlD
Cefadroxil—Cephalexin—CYP3A4—type 2 diabetes mellitus	0.0001	0.0423	CrCbGaD
Cefadroxil—Headache—Ramipril—type 2 diabetes mellitus	0.0001	0.000529	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	9.95e-05	0.00589	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	9.9e-05	0.00586	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	9.85e-05	0.00583	CbGpPWpGaD
Cefadroxil—Cefalotin—ALB—type 2 diabetes mellitus	9.62e-05	0.0406	CrCbGaD
Cefadroxil—Nausea—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000502	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	9.47e-05	0.0056	CbGpPWpGaD
Cefadroxil—SLC22A5—retina—type 2 diabetes mellitus	9.43e-05	0.0489	CbGeAlD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	9.31e-05	0.00551	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	9.23e-05	0.00546	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	9.14e-05	0.00541	CbGpPWpGaD
Cefadroxil—SLC15A1—liver—type 2 diabetes mellitus	9.07e-05	0.0471	CbGeAlD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	8.99e-05	0.00532	CbGpPWpGaD
Cefadroxil—SLC15A2—kidney—type 2 diabetes mellitus	8.97e-05	0.0466	CbGeAlD
Cefadroxil—SLC22A5—nephron tubule—type 2 diabetes mellitus	8.88e-05	0.0461	CbGeAlD
Cefadroxil—Cephalexin—ALB—type 2 diabetes mellitus	8.75e-05	0.0369	CrCbGaD
Cefadroxil—SLC15A2—cortex of kidney—type 2 diabetes mellitus	8.74e-05	0.0453	CbGeAlD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	8.59e-05	0.00508	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	8.42e-05	0.00498	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	8.31e-05	0.00492	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	8.26e-05	0.00489	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.2e-05	0.00485	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	8.13e-05	0.00481	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	8.04e-05	0.00476	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.83e-05	0.00463	CbGpPWpGaD
Cefadroxil—SLC22A5—kidney—type 2 diabetes mellitus	7.8e-05	0.0405	CbGeAlD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.77e-05	0.0046	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.77e-05	0.0046	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.64e-05	0.00452	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	7.61e-05	0.0045	CbGpPWpGaD
Cefadroxil—SLC22A5—cortex of kidney—type 2 diabetes mellitus	7.6e-05	0.0394	CbGeAlD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	7.48e-05	0.00443	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.47e-05	0.00442	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.34e-05	0.00435	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.26e-05	0.0043	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.21e-05	0.00427	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.21e-05	0.00427	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.14e-05	0.00423	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.11e-05	0.00421	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.09e-05	0.0042	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.09e-05	0.0042	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.09e-05	0.0042	CbGpPWpGaD
Cefadroxil—SLC22A5—adipose tissue—type 2 diabetes mellitus	7.03e-05	0.0365	CbGeAlD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	7.03e-05	0.00416	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	6.97e-05	0.00413	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	6.79e-05	0.00402	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	6.77e-05	0.00401	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	6.64e-05	0.00393	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.59e-05	0.0039	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.49e-05	0.00384	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	6.46e-05	0.00382	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	6.41e-05	0.0038	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	6.41e-05	0.0038	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.35e-05	0.00376	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.33e-05	0.00375	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.33e-05	0.00375	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	6.31e-05	0.00373	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.1e-05	0.00361	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.1e-05	0.00361	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.09e-05	0.0036	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.99e-05	0.00354	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	5.89e-05	0.00349	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.88e-05	0.00348	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.88e-05	0.00348	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	5.87e-05	0.00347	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	5.79e-05	0.00343	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.78e-05	0.00342	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.78e-05	0.00342	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.66e-05	0.00335	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.66e-05	0.00335	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	5.65e-05	0.00334	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	5.65e-05	0.00334	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.56e-05	0.00329	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.56e-05	0.00329	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.56e-05	0.00329	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	5.56e-05	0.00329	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	5.54e-05	0.00328	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.54e-05	0.00328	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.47e-05	0.00324	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	5.39e-05	0.00319	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	5.35e-05	0.00317	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	5.35e-05	0.00317	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	5.26e-05	0.00312	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	5.24e-05	0.0031	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.23e-05	0.00309	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.23e-05	0.00309	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.18e-05	0.00307	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.18e-05	0.00306	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.14e-05	0.00304	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.05e-05	0.00299	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.03e-05	0.00298	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.03e-05	0.00298	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	5.02e-05	0.00297	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.01e-05	0.00296	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	4.94e-05	0.00293	CbGpPWpGaD
Cefadroxil—SLC22A5—liver—type 2 diabetes mellitus	4.93e-05	0.0256	CbGeAlD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.9e-05	0.0029	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.81e-05	0.00285	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	4.8e-05	0.00284	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.8e-05	0.00284	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.73e-05	0.0028	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	4.72e-05	0.0028	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.65e-05	0.00275	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.57e-05	0.0027	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.57e-05	0.0027	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.45e-05	0.00264	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.38e-05	0.00259	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	4.37e-05	0.00259	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	4.36e-05	0.00258	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	4.36e-05	0.00258	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.28e-05	0.00253	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	4.27e-05	0.00253	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	4.2e-05	0.00249	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	4.2e-05	0.00249	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	4.19e-05	0.00248	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.17e-05	0.00247	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.13e-05	0.00245	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	4.13e-05	0.00244	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.98e-05	0.00235	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.98e-05	0.00235	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.96e-05	0.00235	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.88e-05	0.0023	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.87e-05	0.00229	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.86e-05	0.00228	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.84e-05	0.00227	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.81e-05	0.00226	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.8e-05	0.00225	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.69e-05	0.00218	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.69e-05	0.00218	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.63e-05	0.00215	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.63e-05	0.00215	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.6e-05	0.00213	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.58e-05	0.00212	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.57e-05	0.00211	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.57e-05	0.00211	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.56e-05	0.00211	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.54e-05	0.0021	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.52e-05	0.00208	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.5e-05	0.00207	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.45e-05	0.00204	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.44e-05	0.00204	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.38e-05	0.002	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.31e-05	0.00196	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.28e-05	0.00194	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.28e-05	0.00194	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.23e-05	0.00191	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.2e-05	0.0019	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.19e-05	0.00189	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.17e-05	0.00187	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.14e-05	0.00186	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.14e-05	0.00186	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.09e-05	0.00183	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.09e-05	0.00183	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.99e-05	0.00177	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.94e-05	0.00174	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.91e-05	0.00172	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.87e-05	0.0017	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.87e-05	0.0017	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.86e-05	0.00169	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.82e-05	0.00167	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.79e-05	0.00165	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.74e-05	0.00162	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.74e-05	0.00162	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.67e-05	0.00158	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.67e-05	0.00158	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.66e-05	0.00158	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.66e-05	0.00157	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.65e-05	0.00157	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.64e-05	0.00156	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.63e-05	0.00156	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.59e-05	0.00153	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.55e-05	0.00151	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.54e-05	0.0015	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.47e-05	0.00146	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.46e-05	0.00146	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.44e-05	0.00144	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.43e-05	0.00144	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.42e-05	0.00143	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.4e-05	0.00142	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.38e-05	0.00141	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.36e-05	0.0014	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.33e-05	0.00138	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.32e-05	0.00137	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.22e-05	0.00132	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.21e-05	0.00131	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.2e-05	0.0013	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.19e-05	0.0013	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.17e-05	0.00128	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.17e-05	0.00128	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.16e-05	0.00128	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.14e-05	0.00127	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.13e-05	0.00126	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.1e-05	0.00124	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.01e-05	0.00119	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.99e-05	0.00118	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.96e-05	0.00116	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.96e-05	0.00116	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.87e-05	0.0011	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.84e-05	0.00109	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.84e-05	0.00109	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.83e-05	0.00108	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.81e-05	0.00107	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.77e-05	0.00105	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.75e-05	0.00104	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.66e-05	0.000983	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.64e-05	0.000969	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.59e-05	0.000943	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.48e-05	0.000875	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.48e-05	0.000874	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.45e-05	0.000861	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.39e-05	0.00082	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.32e-05	0.000778	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.1e-05	0.00065	CbGpPWpGaD
